Cargando…

Impacts of post‐radiotherapy lymphocyte count on progression‐free and overall survival in patients with stage III lung cancer

BACKGROUND: We evaluated the impact of thoracic radiation in patients with non‐small cell lung cancer (NSCLC), considering the depletion of total lymphocytes, use or not of chemotherapy, and radiation doses in healthy lung tissue. METHODS: Patients with stage III NSCLC, ECOG 0 to 2, receiving radiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matiello, Juliana, Dal Pra, Alan, Zardo, Laise, Silva, Ricardo, Berton, Danilo C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606004/ https://www.ncbi.nlm.nih.gov/pubmed/32956564 http://dx.doi.org/10.1111/1759-7714.13621

Ejemplares similares

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
por: Zhao, Qianqian, et al.
Publicado: (2019)

Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023)

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017)

Contemporary role of postoperative radiotherapy for prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2018)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy
por: Malla, Bijaya, et al.
Publicado: (2018)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort study
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
por: Aft, R L, et al.
Publicado: (2012)

Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Xu, Hongen, et al.
Publicado: (2019)

Low plateletcrit is associated with reduced progression: Free and overall survival in chronic lymphocytic leukemia
por: Ozbalci, Demircan, et al.
Publicado: (2023)

Presence of bone marrow micro‐metastases in stage I‐III colon cancer patients is associated with worse disease‐free and overall survival
por: Viehl, Carsten T., et al.
Publicado: (2017)

Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer
por: Park, Se Jun, et al.
Publicado: (2021)

Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer
por: Kanzaki, Hiromitsu, et al.
Publicado: (2021)

Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation
por: Yu, Yishan, et al.
Publicado: (2020)

Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

Prognostic Significance of Initial Absolute Lymphocyte Count in Adjuvant Radiotherapy for Pancreatic Adenocarcinoma
por: Heo, Jaesung, et al.
Publicado: (2022)

Is increasing nodal count associated with improved recurrence‐free and overall survival following standard right hemicolectomy for colon cancer?
por: Hayes, Ian P., et al.
Publicado: (2022)

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients
por: De Logu, Francesco, et al.
Publicado: (2021)

Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
por: Bojaxhiu, Beat, et al.
Publicado: (2018)

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
por: Price, James M., et al.
Publicado: (2022)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
por: Gray, Jhanelle E., et al.
Publicado: (2019)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort
por: Shi, Yi-Yun, et al.
Publicado: (2015)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Peripheral Lymphocyte Counts and Lymphocyte-Related Inflammation Indicators During Radiotherapy for Pelvic Malignancies: Temporal Characterization and Dosimetric Predictors
por: Xiang, Xiaoyong, et al.
Publicado: (2022)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
por: Li, Qingguo, et al.
Publicado: (2017)

Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Shelan, Mohamed, et al.
Publicado: (2019)

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab
por: Nindra, Udit, et al.
Publicado: (2022)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma
por: Somasundaram, Eashwar, et al.
Publicado: (2023)

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
por: Yang, Fei, et al.
Publicado: (2018)

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
por: Chu, Hee Ho, et al.
Publicado: (2021)

Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1i7mks5ngkci8tte0r3h2c8673